Maximus Review

Our assessment

Maximus prints the plan length beside every figure, which is the single most useful thing a price page can do: a twelve-month rate can never be mistaken here for a month-to-month one. It charges no membership, says so twice on separate product pages, and sells brand-name Zepbound at a posted cash price with the multi-dose pen costing the same as the vial. You pay for that clarity in the rate itself — the no-commitment semaglutide figure is higher than its prepaid rates — and the doctors Maximus puts on its site are an advisory board, not the people who write your prescription.

Every number has its term printed next to it

Maximus publishes three plan lengths for each compounded drug — one month, four months, twelve months — with each figure sitting beside the term it belongs to. There is no headline rate whose condition you have to hunt for.

That sounds small. It isn't. Two hundred and twenty-eight of the four hundred and twenty sellers in this comparison have a price-stability problem: a promotional first month, a tier requirement, a discount with no expiry, or two prices for one product. Maximus has none of those.

It also publishes a personalized-dose floor beneath each headline plan, so the cheapest figure the program can produce is visible rather than implied. The trade is real, though. The rate that holds with no commitment is the one-month one, and the cheaper figures require signing up for four months or a year.

The no-commitment rate is expensive

Compare like with like and Maximus is not cheap. Its one-month semaglutide rate is higher than its longer-commitment rates. Compare the total commitment as well as the monthly figure.

The twelve-month figures are competitive. They are also a year of your money committed, in exchange for about two-fifths off the semaglutide rate and about a third off the tirzepatide one.

So treat Maximus as two different products. If you know you are staying on treatment for a year and will actually take the annual plan, the price is fine. If you want to try a month, you are paying near the top of the market for the privilege of not committing.

No membership, stated twice and defined

The tirzepatide page carries no membership fees, transparent pricing in its own checklist. The Zepbound page prints no hidden fees and no membership directly beside the price. Elsewhere the site describes its pricing as direct-pay covering doctor visits, medications and ongoing support.

One hundred and twenty-nine of the four hundred and twenty sellers here charge no membership, so Maximus is not alone. It is one of the clearer statements of it, though, because it also says what the price covers rather than only what it doesn't — visits, medication, support. That turns a negative claim into a scope statement.

For anyone comparing across boards, that matters more than the headline. A Maximus month is one charge. Forty-six of the four hundred and twenty sellers here bill a separate membership on top of the drug, and their advertised figures are not the same kind of number.

Brand Zepbound at a posted price, pen and vial alike

Maximus sells brand-name Zepbound at a published self-pay figure, and charges the same for the multi-dose pen as for the vial. One hundred and eighteen of the four hundred and twenty sellers here offer a brand route at all, and fewer post a figure for the pen presentation specifically.

The pen matters practically. It is ready to use, with no drawing up from a vial, and paying no premium for that convenience is a genuine point in Maximus's favor.

The page sets no compounded figure against the brand one the way a couple of sellers here do, since the brand product lives on its own page. But both figures are public, and both carry the no-membership language.

Advisory doctors are not prescribing doctors

Maximus names several physicians, and they are real people with real credentials. Its own page calls them a clinical advisory team, and they are largely academics. The founder is a clinical psychologist.

None of them is presented as your prescriber or as a medical director. Ask who writes the prescription and the answer stays generic: US-based, fully licensed, board-certified physicians, with no individual attached. Forty of the sellers here name a prescriber. Maximus is not one of them.

The pharmacy is unnamed too. Maximus describes its vetting process instead — US-based, fully licensed compounding pharmacies operating to USP standards. Ninety-four of the four hundred and twenty sellers here name one.

Three states are excluded from the weight program outright, and Maximus says so in a single plain sentence rather than making you assemble it from footnotes. That is better disclosure than most, and it is a hard no if you live in one of them.